ALKEM LABORATORIES LIMITED

Communiqués Alkem Laboratories Limited

Actions

ALKEM

INE540L01014

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:49:39 19/05/2025			Varia. 5j.	Varia. 1 janv.
5 324,00 ^INR	+1,97%		+7,63%	-5,50%

16/05	La filiale américaine d'Alkem Laboratories victime d'une cyberattaque	MT
23/04	Alkem Laboratories acquiert 100 % des parts d'Adroit Biomed	RE

Communiqués

Biosergen Completes Enrollment of First Cohort in BSG005 Proof-of-Concept Trial	07/10/24	AQ
Legal Insights On Pharma Trademark Similarity And Confusion	19/09/24	AQ
Exactech Enters Landmark Agreement with Alkem MedTech Pvt Ltd for Manufacturing and Marketing Knee and Hip Replacement Implants in India	23/08/24	AQ
Exactech and Alkem MedTech form partnership to begin distribution of knee and hip replacement technology in India	23/08/24	AQ
First Patient in Biosergen Clinical Trial Treating with BSG005 for Life Threatening Fungal Infection	12/07/24	AQ
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12/02/24	AQ
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16/01/24	AQ
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	12/12/23	AQ
Biosergen and Alkem Laboratories Ltd collaborates to develop anti-infective for severe fungal infections	25/09/23	AQ
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India	10/03/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT